Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

*Name of Committee:*                         Recombinant DNA Advisory Committee.                    

*Date:*                         December 3-5, 2007.                    

*Time:*                         December 3, 2007, 8 a.m. to 1 p.m.                    

*Agenda:*                         The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols as well as related data management activities. There will also be follow-ups on Consideration of a Proposed Major Action under section III-A-1 of the NIH Guidelines for Research Involving Recombinant DNA Molecules and on a serious adverse event on a gene transfer trial using an AAV vector.                    

*Place:*                         National Institutes of Health, Building 31, Floor 6C, 31 Center Drive, Conference Room 10, Bethesda, MD 20892.                    

*Time:*                         December 4, 2007, 8 a.m. to 3 p.m.                    

*Agenda:*                         Continued.                    

*Place:*                         National Institutes of Health, Building 31, Floor 6C, 31 Center Drive, Conference Room 10, Bethesda, MD 20892.                    

*Time:*                         December 5, 2007, 8 a.m. to 10:30 a.m.                    

*Agenda:*                         Continued.                    

*Place:*                         National Institutes of Health, Building 31, Floor 6C, 31 Center Drive, Conference Room 10, Bethesda, MD 20892.                    

*Contact Person:*                         Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 301-496-9838,                         *lewallla@od.nih.gov.*

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

                        In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles,                               ( print page 63918)                            including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.                    

                        Information is also available on the Institute's/Center's home page:                         *http://www4.od.nih.gov/​oba/​,*                         where an agenda and any additional information for the meeting will be posted when available.                    

OMB's “Mandatory Information Requirements for Federal Assistance Program Announcements” (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or in the public interest to list these programs. Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many Federal agencies, as well as private organizations, both national and international,  have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites readers to direct questions to the  information address above about whether individual programs listed in the Catalog of Federal Domestic Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Dated: November 2, 2007.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-5616 Filed 11-9-07; 8:45 am]

BILLING CODE 4140-01-M